How Our Environment Speaks to Our Genes

The Exposome: Your Lifetime Environmental Fingerprint

The exposome, a concept introduced by epidemiologist Christopher Wild in 2005, encompasses every environmental exposure an individual encounters from conception to death — including chemical pollutants, diet, radiation, infections, psychosocial stressors, and the built environment. Unlike the genome (fixed at conception), the exposome is continuously evolving, and its cumulative impact on gene expression is now understood to exceed the contribution of genetic variation alone in determining health outcomes. The exposome operates through four interconnected biological layers: the transcriptome (which genes are being actively read and transcribed into RNA), the metabolome (the complete set of small-molecule metabolites produced by cellular processes), the proteome (the full complement of proteins expressed), and ultimately the phenome — the observable physical and biochemical characteristics that emerge from this complex interplay.

Transcriptome, Metabolome, and Phenome: The Biological Cascade

When an environmental signal reaches a cell, it initiates a cascade through the biological layers of the exposome response. The transcriptome — the complete set of RNA transcripts produced by the genome at any given moment — is the first responder. Environmental toxins, nutrients, and stressors alter transcription factor binding, chromatin accessibility, and RNA polymerase activity, changing which genes are expressed and at what level. These transcriptomic changes ripple downstream into the metabolome: altered gene expression produces different enzymes, which in turn produce different metabolites. Metabolomic shifts — changes in the concentrations of amino acids, lipids, organic acids, and signalling molecules — reflect the biochemical state of the cell and the organism. The phenome represents the ultimate output: the observable traits, disease susceptibilities, and physiological characteristics that emerge from the interaction of genome, exposome, transcriptome, and metabolome across a lifetime.

• Transcriptome — the complete set of RNA transcripts; first responder to environmental signals
• Metabolome — ~100,000 small molecules reflecting real-time cellular biochemistry
• Proteome — the full protein complement; bridges gene expression and cellular function
• Phenome — observable traits and disease patterns emerging from all biological layers
• Epigenome — the layer of chemical marks on DNA and histones that regulate transcription in response to environment

Heavy Metals and Gene Expression: Evidence from Mining Communities

Among the most compelling evidence for environmental gene alteration comes from studies of populations living near industrial mining operations. A landmark 2017 study by Korashy HM et al. examined gene expression profiles in residents of a mining town with documented heavy metal contamination — including lead, arsenic, cadmium, and mercury. The findings were striking: 2,129 genes showed significant alterations in expression compared to unexposed controls. The affected genes spanned pathways including DNA damage response, oxidative stress signalling, immune regulation, inflammatory cascades, and endocrine function. Heavy metals exert their gene-altering effects through multiple mechanisms: direct binding to DNA and histones, displacement of essential metal cofactors in enzymes, generation of reactive oxygen species that damage DNA and alter methylation patterns, and activation of stress-response transcription factors including NF-κB, Nrf2, and the aryl hydrocarbon receptor (AhR). The scale of gene expression change documented in this study — over two thousand genes — underscores that heavy metal exposure is not a minor biochemical inconvenience but a profound reprogramming of cellular function.

Persistent Organic Pollutants, PCBs, and Sex-Specific Gene Expression

Persistent organic pollutants (POPs) — including polychlorinated biphenyls (PCBs), dioxins, furans, and organochlorine pesticides — are among the most biologically disruptive environmental contaminants. Unlike heavy metals, POPs are lipophilic: they accumulate in fatty tissues and are extraordinarily resistant to metabolic breakdown, persisting in the body for decades. PCBs exert their gene-regulatory effects primarily through the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor that, when bound by PCBs, translocates to the nucleus and alters the expression of hundreds of genes involved in xenobiotic metabolism, immune function, hormonal signalling, and cell cycle regulation. Research comparing gene expression patterns in girls with high versus low levels of POPs and PCBs has revealed dramatically different transcriptomic profiles. Girls with elevated POP/PCB levels show upregulation of genes involved in inflammatory signalling, oestrogen metabolism, thyroid hormone disruption, and immune dysregulation — alongside suppression of genes governing antioxidant defence and DNA repair. These differences are not merely statistical: they correspond to measurable differences in pubertal timing, immune competence, thyroid function, and metabolic health. The sex-specific nature of these effects reflects the interaction between POPs and oestrogen signalling pathways, making girls and women particularly vulnerable to the gene-expression consequences of persistent organic pollutant exposure.

Phthalates, Metabolic Disease, and the Australian Evidence

Phthalates are synthetic plasticisers found ubiquitously in food packaging, personal care products, medical devices, and building materials. Unlike POPs, phthalates are not persistent — they are rapidly metabolised and excreted — but their ubiquity means continuous re-exposure maintains chronically elevated body burdens. A significant 2017 study by Bai PY et al. examined phthalate metabolite levels in Australian men and found robust associations between urinary phthalate concentrations and three major metabolic conditions: type 2 diabetes, hypertension, and systemic inflammation. The biological mechanisms linking phthalates to these outcomes operate through multiple gene-regulatory pathways. Phthalates are potent peroxisome proliferator-activated receptor (PPAR) agonists — activating PPAR-γ and PPAR-α, which regulate adipogenesis, insulin sensitivity, and lipid metabolism. They also act as androgen receptor antagonists, disrupting testosterone signalling and contributing to insulin resistance and metabolic syndrome. At the transcriptomic level, phthalate exposure alters expression of genes governing glucose transport (GLUT4), inflammatory cytokine production (IL-6, TNF-α, CRP), and vascular tone regulation — providing mechanistic explanations for the diabetes, hypertension, and inflammation associations documented in the Bai PY et al. cohort.

The Phenome: Where Environment Becomes Biology

The phenome is the ultimate readout of the exposome's influence on the genome. It encompasses not just visible physical traits but the full spectrum of biochemical, physiological, and disease phenotypes that emerge from a lifetime of gene-environment interaction. Phenomic research — using high-throughput measurement of thousands of phenotypic variables simultaneously — is revealing that environmental exposures leave distinctive 'fingerprints' in the phenome. Heavy metal exposure produces a phenomic signature characterised by elevated oxidative stress markers, impaired immune function, and altered neurological parameters. POP/PCB exposure produces a phenomic signature of hormonal disruption, immune dysregulation, and metabolic abnormality. Phthalate exposure produces a phenomic signature of insulin resistance, vascular dysfunction, and chronic low-grade inflammation. Understanding these phenomic signatures allows clinicians to work backwards from observable health patterns to identify likely environmental exposures — and to design targeted interventions that address the specific gene expression pathways that have been disrupted.

• Heavy metals (Pb, As, Cd, Hg) — 2,129 genes altered; pathways: DNA damage, oxidative stress, immune dysregulation (Korashy HM et al., 2017)
• PCBs and POPs — AhR-mediated transcriptomic reprogramming; sex-specific effects on oestrogen, thyroid, and immune gene expression
• Phthalates — PPAR agonism and androgen antagonism; diabetes, hypertension, and inflammation gene expression changes (Bai PY et al., 2017)
• Air pollution (PM2.5) — epigenetic clock acceleration, inflammatory gene upregulation, cardiovascular gene expression changes
• Pesticides (organophosphates) — cholinesterase inhibition, neurodevelopmental gene expression disruption, endocrine pathway alteration

Reducing Your Exposome Burden: Clinical Strategies

While complete avoidance of environmental toxins is impossible in the modern world, targeted strategies can significantly reduce exposome burden and support the gene expression pathways most vulnerable to environmental disruption. Dietary interventions are foundational: cruciferous vegetables (sulforaphane activates Nrf2 and Phase II detoxification genes), polyphenol-rich foods (quercetin, resveratrol, curcumin modulate AhR and NF-κB), and adequate protein (provides cysteine for glutathione synthesis) all support the body's endogenous detoxification transcriptome. Reducing plastic exposure — switching to glass and stainless steel food storage, filtering drinking water, choosing fragrance-free personal care products — meaningfully lowers phthalate and BPA body burden. Supporting methylation (methylated B vitamins, choline, betaine) enhances the epigenetic resilience of the genome to environmental insults. Clinical testing of heavy metals (blood and urine), urinary phthalate metabolites, and persistent organic pollutants (serum lipid-adjusted) allows personalised assessment of individual exposome burden and guides targeted detoxification protocols.

• Sulforaphane (broccoli sprouts) — activates Nrf2 and Phase II detoxification enzyme gene expression
• Glutathione support (NAC, glycine, selenium) — enhances heavy metal and POP conjugation and excretion
• Methylated B vitamins — support epigenetic resilience and methylation-dependent detoxification pathways
• Reduce plastic exposure — glass/stainless storage, water filtration, fragrance-free personal care products
• Clinical testing — urinary phthalate metabolites, blood/urine heavy metals, serum POPs for personalised exposome assessment